Cargando…
A cost-effectiveness analysis of varenicline for smoking cessation using data from the EAGLES trial
BACKGROUND: The cost-effectiveness of varenicline has been demonstrated in the US health care setting using the Benefits of Smoking Cessation on Outcomes (BENESCO) model to simulate the lifetime direct costs and consequences of a hypothetical cohort of US adult smokers who make a single attempt to q...
Autores principales: | Baker, Christine L, Pietri, Guilhem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783141/ https://www.ncbi.nlm.nih.gov/pubmed/29403297 http://dx.doi.org/10.2147/CEOR.S153897 |
Ejemplares similares
-
Smoking cessation therapy with varenicline
por: Mohanasundaram, Uma M, et al.
Publicado: (2008) -
Smoking cessation: an economic analysis and review of varenicline
por: Faulkner, Michele A
Publicado: (2009) -
Smoking cessation in Asians: focus on varenicline
por: Xiao, Dan, et al.
Publicado: (2015) -
Smoking cessation in Asians: focus on varenicline [Corrigendum]
Publicado: (2015) -
Smoking Cessation Pharmacogenetics: Analysis of Varenicline and Bupropion in Placebo-Controlled Clinical Trials
por: King, David P, et al.
Publicado: (2012)